• Press Release

Stem Cell Memories May Hold Answer to Their Reproduction, Mount Sinai Study Finds

  • New York, NY
  • (December 09, 2016)

Blood-forming stem cells are able to count and store memories of the number of times that they divide, findings which could have major implications for disease research, scientists at the Icahn School of Medicine at Mount Sinai have found. Their study appeared in the November 17 issue of Cell.

Hematopoietic stem cells (HSCs) are stem cells that reside in bone marrow and are responsible for maintaining the continuous production of blood throughout life. HSCs have been used clinically for decades to treat various blood-borne illnesses ranging from leukemia to severe combined immunodeficiency syndrome. However, a major barrier to treatment is the limited availability of stem cells. Clinicians and researchers have worked to expand stem cell numbers, but have been largely unsuccessful at facilitating reproduction of these cells. This research provides clues as to why these efforts have not succeeded – because these cells count and retain a memory of their divisions, which control their potential for further reproduction.

According to the researchers, the study found that slow cycling cells contained all of the long-term HSC activity among the aging cells in the bone marrow. The data collected further shows that age-related changes to the HSCs, including HSC expansion, are dependent on the cells knowing how many times they have divided.

“What this essentially means is that these important stem cells remember how many times they have divided, and those memories control how they will self-renew in the future,” said Kateri Moore, DVM, Associate Professor of Cell, Developmental and Regenerative Biology at the Icahn School of Medicine at Mount Sinai. “This knowledge may be able to help us find the key to expanding the numbers of these cells for therapeutic and research use.”

Both Dr. Moore and the lead author Jeffrey Bernitz, a PhD candidate at the Icahn School of Medicine at Mount Sinai, hope that the results of this study will provide additional clues that will help us achieve stem cell expansion in the future.


About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.